KLOPIDOGREL'PRI OSTROM KORONARNOM SINDROME I ChRESKOZhNYKh KORONARNYKh VMEShATEL'STVAKh
- Authors: UDOVIChENKO A1, SULIMOV V1
-
Affiliations:
- Issue: Vol 5, No 2 (2005)
- Pages: 46-49
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117583
- ID: 117583
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
References
- Berger P.B., Bell M.R., Grill D.E., Melby S., Holmes D.R. Jr. Frequency of adverse clinical events in the 12 months followingsuccessful intracoronary stent placement in patients treated with aspirin and ticlopidine (without warfarin) // Am. J. Cardiol., 1998; 81: 713-718.
- Bertrand M.E., Legrand V., Boland J. et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study // Circulation 1998; 98: 1597-1603.
- Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA 2002 guideline updates for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation - 2002; 106: 1893-1900.
- CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee // Lancet. - 1996; 348: 1329-1339.
- Harker L.A., Boissel J.-P., Pilgrim A.J., Gent M., on behalf of the CAPRIE steering committee and investigators. Comparative safety and tolerability of clopidogrel and aspirin. Results from CAPRIE. // Drug Saf. - 1999; 21: 325-335.
- Mehta S.R., Yusuf S., Peters R.J. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study // Lancet. - 2001; 358: 527-533.
- Peters R.J., Mehta S.R., Fox K.A. et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study // Circulation. - 2003; 108: 1682-1687.
- Ryan T.J., Antman E.M., Brooks N.H. et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendation: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) // Circulation. - 1999; 100: 1016-1030.
- Smith S.C., Dove J.T., Jacobs A.K. et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty) // Circulation. - 2001; 103: 3019-3041.
- Steinhubl S.R., Berger P.B., Mann J.T. et al, for the CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percuta- neous coronary intervention. A randomized controlled trial. // JAMA. - 2002; 288: 2411-2420.
- Urban P., Macaya C., Rupprecht H.J. et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS). // Circulation. - 1998; 98: 2126-2132.
- US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale // Ann Intern. Med. - 2002; 136: 157-160.
Supplementary files
